Evidence map›Paper›PMID 41066428›Full record

ArticlePloS one2025

Bacteriophage as an anti-biofilm agent against Pseudomonas aeruginosa from wound infection.

Padma Shrestha, Sujit Tandukar, Manisha Shrestha, Sanjit Shrestha, Anup Subedee, Jivan Shakya, Reshma Tuladhar

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Modeling the phage properties best for therapy.bioRxiv : the preprint server for biology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Padma ShresthaInstitute for Research in Science and Technology, Lalitpur, Nepal.ORCID https://orcid.org/0009-0006-8260-022X
Sujit TandukarInstitute for Research in Science and Technology, Lalitpur, Nepal.ORCID https://orcid.org/0009-0003-8116-5199
Manisha ShresthaInstitute for Research in Science and Technology, Lalitpur, Nepal.ORCID https://orcid.org/0009-0009-5474-6442
Sanjit ShresthaPathology Department, Kirtipur Hospital, Nepal.
Anup SubedeeDepartment of Internal Medicine, Public Health Concern Trust (PHeCT)-Nepal Kirtipur Hospital.
Jivan ShakyaInstitute for Research in Science and Technology, Lalitpur, Nepal.ORCID https://orcid.org/0000-0001-9469-2148
Reshma TuladharCentral Department of Microbiology, Tribhuvan University, Kirtipur, Nepal.ORCID https://orcid.org/0000-0001-9583-5374

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pseudomonas aeruginosa, an opportunistic pathogen associated with wound infections, resists many commonly available antibiotics. Its ability to form biofilm provides an additional trait to evade antibiotics. Biofilm-associated infections are difficult to treat, raising the need for alternative strategies. Thus, this research aimed to investigate the potential of bacteriophage to disrupt the biofilm produced by P. aeruginosa isolated from wound infections. Wound samples were collected aseptically, processed for the isolation of P. aeruginosa, and identified by standard microbiological methods. Antimicrobial susceptibility was determined by the Kirby-Bauer disc diffusion method. Bacteriophages were isolated using the double-layer agar method. Phenotypic assessment of biofilm formation by the isolates and its reduction by phages was conducted by the tissue culture plate assay. Out of 647 wound samples processed, 96 P. aeruginosa were isolated. Piperacillin/tazobactam was the most effective antibiotic, while doxycycline was the least effective. Among the total isolates, 86 (89.6%) were multidrug-resistant (MDR) and 69 (71.9%) were biofilm producers. Three different phages isolated from sewage demonstrated a high specificity to P. aeruginosa. Of these, phage vB_PaeP_PS2 lysed the highest number of isolates (22.9%), including 17 MDR and 21 biofilm-producing isolates. The biofilm reduction assay demonstrated that phage treatment significantly reduced biofilm formation, with vB_PaeP_PS2 achieving a 58% reduction after 6 h of treatment. In conclusion, this study highlights the high prevalence of biofilm-producing MDR P. aeruginosa in wound infections and, for the first time in Nepal, demonstrates the potential of locally isolated phages to lyse biofilm-forming MDR isolates and disrupt their biofilms.

Indexed as

BacteriophagesBiofilmsPseudomonas aeruginosaPseudomonas InfectionsPseudomonas PhagesWound InfectionAnti-Bacterial AgentsDrug Resistance, Multiple, BacterialHumansMicrobial Sensitivity TestsPhage TherapyAnti-Bacterial Agents

Identifiers

PMID41066428
PMCPMC12510511

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.